Topic: WorldNetDaily
In February, we caught WorldNetDaily's Art Moore promoting a "new, peer-reviewed study finds that one of the cheap, widely available drugs that has been dismissed by the left, establishment media and many in the health establishment as a treatment for COVID-19 reduces infections, hospitalizations and deaths by about 75%," to be published in the journal Frontiers of Pharmacology. But a week after Moore's article appeared, the journal withdrew the article -- manufactured by a group called the Front Line COVID-19 Critical Care Alliance, which was formed to push unapproved treatments like ivermectin -- before actual publication, stating that it contained unsubstantiated claims and violated the journal’s editorial policies.
Despite the fact that the study was never actually published, Moore has continued to falsely promote the study as "peer-reviewed" and published.
In a May 2 article, Moore largely copied-and-pasted from his original (and now false) Feb. 25 piece:
In February, a peer-reviewed study found that ivermectin – which has been shown to inhibit the replication of SARS-CoV-2 in cell cultures – reduces infections, hospitalizations and deaths by about 75%. In more than 30 trials around the world it caused "repeated, consistent, large magnitude improvements in clinical outcomes’ at all stages of the disease," according to the study published in the U.S. journal Frontiers of Pharmacology
The evidence is so strong, the researchers believe, the anti-parasitic drug should become a standard therapy everywhere, hastening global recovery."The data is overwhelming – we are in a pandemic, and this is an incredibly effective way to combat it. If we use ivermectin widely, our societies can open up," said study co-author Professor Paul Marik, director of emergency and pulmonary care at Eastern Virginia Medical School.
Moore did another false plug in a May 10 article:
In February, a study published in the U.S. journal Frontiers of Pharmacology found ivermectin reduces COVID-19 infections, hospitalizations and deaths by about 75%. In more than 30 trials around the world, the drug causes "repeated, consistent, large magnitude improvements in clinical outcomes’ at all stages of the disease," according to the study.
The latest study was led by the Front Line COVID-19 Critical Care Alliance, or FLCCC, a group of medical and scientific experts who are researching and promoting drugs such as ivermectin and hydroxycloroquine as an effective prophylaxis and treatment for COVID-19.
"We did the work that the medical authorities failed to do, we conducted the most comprehensive review of the available data on ivermectin," said Pierre Kory, president and chief medical officer of the FLCCC.
"We applied the gold standard to qualify the data reviewed before concluding that ivermectin can end this pandemic."
Those quotes from Kory actually come from a FLCCC press release announcing publication of a version of its study in the American Journal of Therapeutics, which is where it landed after Frontiers in Pharmacology rejected it.
Moore was still repeating the false claim in a May 17 article:
In February, a peer-reviewed study found that invermectin reduces coronavirus infections, hospitalizations and deaths by about 75%.
Ivermectin, in more than 30 trials around the world, causes "repeated, consistent, large magnitude improvements in clinical outcomes’ at all stages of the disease," according to the study, which was published in the U.S. journal Frontiers of Pharmacology.
Moore's reporting has been factually inaccurate and dishonest. It's what we've come to expect from WND, but it's not what WND needs if it wants people to pay for its so-called reporting.
